SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001576885-24-000056
Filing Date
2024-04-22
Accepted
2024-04-22 16:31:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 12071
2 GRAPHIC acumendefa14ainbw001.jpg GRAPHIC 170408
3 GRAPHIC acumendefa14ainbw002.jpg GRAPHIC 63487
  Complete submission text file 0001576885-24-000056.txt   335367
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40551 | Film No.: 24861584
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)